Purchase Order 36C26225P0997

This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The contract, valued at $49,748.73, is for the provision of Novocure's Optune line of Tumor Treating Fields (TTFields) therapy devices, transducer arrays, rental equipment, and associated support services.

The contract does not utilize any set-aside designations. Novocure acts as the prime contractor, delivering its proprietary cancer treatment technologies directly to various VA medical centers nationwide. This contract is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which provides a streamlined procurement vehicle for the VA to efficiently obtain Novocure's Optune TTFields therapy products and services. The primary purpose of this contract is to support the VA's mission of expanding veterans' access to cutting-edge cancer therapies by enabling VA facilities to offer Novocure's non-invasive treatment option to veteran patients diagnosed with glioblastoma, mesothelioma, and other forms of solid tumor cancers.